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Abstract Bio-nanopatterning of surfaces is a very active
interdisciplinary ﬁeld of research at the interface between
biotechnology and nanotechnology. Precise patterning of
biomolecules on surfaces with nanometre resolution has
great potential in many medical and biological applica-
tions ranging from molecular diagnostics to advanced
platforms for fundamental studies of molecular and cell
biology. Bio-nanopatterning technology has advanced at a
rapid pace in the last few years with a variety of pattern-
ing methodologies being developed for immobilising
biomolecules such as DNA, peptides, proteins and viruses
at the nanoscale on a broad range of substrates. In this
review, the status of research and development are
described, with particular focus on the recent advances on
the use of nanolithographic techniques as tools for bio-
molecule immobilisation at the nanoscale. Present
strengths and weaknesses, as well future challenges on the
different nanolithographic bio-nanopatterning approaches
are discussed.
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Introduction
Bio-nanopatterning of surfaces have been [1–4] of growing
interest in recent years, from both scientiﬁc and techno-
logical points of view. Such artiﬁcial biological surfaces
can be tremendously useful in diverse biological and med-
ical applications, including nanobiochips, nanobiosensors,
tissue engineering, drug screening, and fundamental studies
of molecular and cell biology [1–7]. Biomolecule nanoarray
technology not only offers the reward of smaller biochips
with more reaction sites, but also smaller test sample vol-
umes and potentially higher sensitivity and throughput
screening for molecular diagnostics [8–11]. With the advent
of DNA hybridisation nanoarrays comes the remarkable
ability to rapidly and effectively monitor the expression
levels of thousands of genes to diagnose and treat illness [1].
In comparison with DNA nanoarrays, protein nanoarrays
offer the possibility of developing a rapid global analysis of
an entire proteome, leading to protein-based diagnostics and
therapeutics [1, 2]. Another area that will proﬁt from this
novel platform technology, thanks to its ﬂexibility in terms
of pattern shape/geometry, is the study of cell adhesion and
motility [12].
These broad range of biological and medical applica-
tions present many challenging materials-design concepts
[1, 2, 4–7]. Prominent among these concepts is the need for
(1) positioning distinct biomolecules within designated
nanoregions in a substrate with well-deﬁned feature size,
shape, and spacing, while retaining their native biological
features and properties and (2) high biomolecule resistively
by the other regions of the substrate. The past few years has
witnessed the advent of several promising strategic meth-
odologies for the aforementioned needs, which are due
primarily to the important advances in nanofabrication
technology.
P. M. Mendes (&)
Department of Chemical Engineering, University of Birmingham,
Edgbaston, Birmingham B15 2TT, UK
e-mail: p.m.mendes@bham.ac.uk
C. L. Yeung   J. A. Preece
School of Chemistry, University of Birmingham, Edgbaston,
Birmingham B15 2TT, UK
123
Nanoscale Res Lett (2007) 2:373–384
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advancement of nanofabrication technology by providing
ideal platforms for engineering surfaces on a molecular
level [13–18]. For instance, self-assembled monolayers
(SAMs), which form spontaneously by the adsorption of an
active surfactant onto a solid surface, possess important
properties of self-organisation and adaptability to a number
of technologically relevant surface substrates. The
properties of a SAM (thickness, structure, surface energy,
stability) can be easily controlled and speciﬁc functional-
ities can also be introduced into the building blocks. SAMs
of thiols on gold [19] and triethoxysilanes on silicon
dioxide (SiO2)[ 20] are examples of two widely used sys-
tems to modify the surface properties of metallic and
inorganic substrates.
The variety of methods [21–25] available to characte-
rise SAMs and other functionalised surfaces with nanoscale
precision has grown in step with the ability to create
sophisticated, nanopatterned surfaces. Scanning probe tech-
niques, such as scanning–tunnelling microscopy [26] and
atomic force microscopy (AFM) [27] are very important
analytical tools that are capable of imaging surfaces down
to the nanometre scale. Aside from their use of nanoscale
topographical imaging [28], scanning probe microscopes
have been widely employed in nanolithography. Further-
more, lithographic techniques developed for the semi-
conductor industry, such as electron-beam lithography
(EBL), have been combined with advanced surface chem-
istry techniques to develop new nanofabrication protocols
[29–31].
Currently a number of methodologies exist for gener-
ating nanoscale features of biomolecules that rely
primarily on the aforementioned nanolithographic tech-
niques. Other methodologies have also been reported that
relate with bottom–up self-assembly approaches [32–38],
redox control [39], conductive AFM [40], scanning-near
ﬁeld photolithography [41] and stamping techniques, such
as imprinting lithography [42–44]. A comprehensive
review of recent efforts in all these directions is beyond
the scope of this review. We instead narrow our focus to
ﬁve promising nanolithographic approaches, which
include dip-pen nanolithography (DPN), nanoshaving,
nanografting, EBL and nanocontact printing (nCP)
(Fig. 1). These patterning techniques have been employed
to either indirectly (processes A, C, D, F and G—Fig. 1)
or directly (processes B, E and H—Fig. 1) immobilise
biomolecules on surfaces. In the indirect approach, the
patterned surfaces are used in a second stage, i.e. post-
patterning process (processes I, J, L and M—Fig. 1), as
templates to immobilise the biomolecules. The current
state-of-the-art as well as the potential and the limitations
of these different nanolithographic approaches are
discussed.
Dip-pen Nanolithography
Dip-pen nanolithography [45] is a scanning probe nano-
patterning technique in which an AFM tip is used to deliver
nanoscale materials directly to nanoscopic regions of a
target substrate. The deposition process involves the inking
of an AFM tip with the nanoscale material, which is then
transferred to the substrate by bringing the AFM tip in
contact with the substrate surface. Once in contact with the
surface, the AFM tip can be either removed from the sur-
face to form dots of the nanomaterial, or scanned across the
surface before being removed, resulting in line patterns.
The inked AFM tip is most commonly scanned across the
substrate in contact mode, however, there have been
reports of the AFM tip being scanned in tapping mode [46,
47] to form nanopatterns. Although the exact tip-substrate
transport mechanism remains unclear, there is some evi-
dences that the ink transport from the tip is mediated by a
water meniscus that forms between the tip and the surface
under atmospheric conditions [45, 48–50]. Among other
factors, water meniscus properties, the tip geometry, the
chemical nature of the ink and substrate, substrate mor-
phology, tip-substrate contact time and writing rate have
been demonstrated [45, 50–57] to have a great effect on the
resolution and contrast of the patterns formed. Early results
showed that DPN could be used to pattern alkanethiol
SAMs onto gold surfaces with dot features as small as
15 nm [51]. Each dot was formed by holding a 16-
mercaptohexadecanoic acid (MHA)-coated tip in contact
(relative humidity 23%) with the gold surface for 10 s.
Parallel probe arrays, which have previously been
investigated for use in data storage [58], have allowed DPN
to develop into a parallel process [51, 59–66]. The use of
tip arrays has been shown to be a technique that can pattern
over square centimetres [59, 67], while still retaining
nanoscale control of the features. For instance, a 55,000-
pen, two-dimensional array has been fabricated [67] that
allowed to reproduce the face of Thomas Jefferson, from a
2005 US ﬁve-cent coin, 55,000 times with nanoscale res-
olution. Perhaps more signiﬁcantly, approximately
4.7 · 10
8 nanofeatures were used to generate the replicas,
and the total time required to perform this fabrication was
less than 30 min. This example of nanostructures formed
by DPN using parallel probes highlights the potential of
DPN as a high-throughput, commercial technique for
applications in the fabrication of bioarrays, for example.
Since DPN offers the ability of routinely working in the
sub-100 nm regime under ambient conditions, which are
critical for patterning biologically active molecules, several
different approaches have been investigated for bio-
nanopatterning of surfaces using this technique. DPN has
been exploited as a tool for indirect immobilisation or
direct write of biomolecules on surfaces.
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In the indirect approach (process A—Fig. 1), the DPN is
used as a tool for preparing afﬁnity arrays out of small
organic molecules that can subsequently direct the immo-
bilisation of biomolecules from solution onto the patterned
surface. Indirect patterning of biomolecules without loss of
activity requires the ability to immobilise these biomole-
cules through speciﬁc interactions that minimise non-
speciﬁc binding. Electrostatic interactions have been
successfully exploited to immobilise the negatively
charged DNA [68, 69] and negatively charged membrane
protein complexes [70] onto protonated amino-terminated
nanotemplates generated by DPN. Carboxylic acid-
terminated monolayers, which exhibit a high afﬁnity for
proteins such as immunoglobulin G (IgG), lysozyme and
retronectin, have also been combined with DPN to create
protein nanostructures (85–350 nm resolution) on gold
surfaces [71–73]. First, gold surfaces were patterned with
MHA SAMs, and the unpatterned regions were passivated
with a protein-resistant oligoethylene glycol (OEG)-
terminated alkanethiol SAM [71]. The proteins were then
adsorbed on the preformed MHA arrays while retaining
their speciﬁcity and biological activity. Nanoarrays of
retronectin, a cellular adhesion protein, with dots of
200 nm in diameter and separated by 700 nm were further
exploited to study cellular adhesion at the nanometre scale.
In addition to proteins, patterned acid-terminated
monolayers have also been used as afﬁnity templates for
immobilising mutant cowpea mosaic virus (CPMV) [74]
and tobacco mosaic virus (TMV) on gold surfaces [75].
The latter being immobilised at single-level on the surface
with the presence of only one TMV particle on each MHA
patterned feature (Fig. 2)[ 75]. The immobilisation
approach relied on the coordination of Zn
2+ metal ions ﬁrst
with the acid groups on the DPN patterned surface and
subsequently with the carboxylate-rich TMV surface.
Coupling reactions have also been investigated to
immobilise biomolecules on patterned surfaces. DNA [76]
and peptide [77] nanoarrays have been fabricated by con-
jugating, through amide bond formation, amine-containing
peptides and DNA to acid-terminated surfaces nanopat-
terned by DPN. Parallel DPN patterning has also been
combined with amine-reactive thiol monolayers to generate
arrays of biologically active proteins over a distance of one
centimetre [78]. First, a SAM of 11-mercaptoundecanoyl-
N-hydroxysuccinimide was patterned onto gold using
multiple-pen cantilever arrays, and the unpatterned regions
Fig. 2 Atomic force microscopy tapping mode images of site-
isolated single TMV virus particles perpendicular to each other [75]
Fig. 1 Schematic
representation of the different
lithographic techniques
employed to indirectly or
directly immobilise
biomolecules on surfaces at
nanometre scale resolution. In
the indirect approach, the
nanopatterns created by the
different lithographic
techniques are used in a second
stage (i.e. post-patterning
process) as templates to
immobilise the biomolecules on
surfaces
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alkanethiol SAM. The N-hydroxysuccinimidyl ester pat-
terned surfaces were then reacted with primary amine
groups in the protein A/G to generate nanoscale arrays of
protein structures. Antibodies were subsequently adsorbed
on the protein A/G nanopatterns and their biological
activity demonstrated by using complementary ﬂuores-
cently labeled antibodies. Although this approach was
limited to the immobilisation of one type of protein, it
demonstrated the capability of DPN to produce protein-
array templates in a relatively high-throughput manner.
Conjugation through amide bond formation was also
combined with DPN to covalently bind amino-terminated
biotin derivates to chemically activated MHA SAM nan-
opatterns [79]. The protein streptavidin was subsequently
linked to the biotin-terminated patterns, providing a plat-
form for molecular recognition-mediated immobilisation of
biotinylated proteins from solution. The widespread
availability of biotinylated biomolecules makes this plat-
form particularly attractive. Streptavidin is a tetrameric
protein which binds four molecules of biotin with extre-
mely high afﬁnity (Ka * 10
13 M
 1)[ 80]. Thus, the
attachment of streptavidin to the biotin-terminated patterns
leaves some biotin unoccupied binding sites, which can be
used subsequently to pattern other biomolecules that
are conjugated with biotin. In order to demonstrate the
potential of this bioconjugation strategy, a streptavidin
nanopatterned surface was incubated with a biotinylated
bovine serum albumin (BSA) protein. This study conﬁrmed
the highly speciﬁc molecular recognition interaction
between the streptavidin on the surface and the biotin-
conjugated BSA [79]. The interaction between biotin
nanopatterned surfaces and a related protein, neutravidin,
has also been exploited by ﬁrst covalently immobilising
amine-reactive N-hydroxysuccinimide functionalised bio-
tin onto amino-terminated monolayers [81].
Another important coupling reaction that has been
employed in conjunction with DPN is based on the cova-
lent linkage between thiol and maleimide groups to afford a
stable thioether bond [74, 82, 83]. For instance, DPN was
used to generate a pattern of circular features (150 nm in
diameter) that presented thiol-reactive maleimide groups at
low density among penta-(ethylene glycol) groups [74].
CPMV particles that were ﬁrst engineered to express cys-
teine thiol groups at the vertices of the icosahedral virus
capsid were then chemospeciﬁcally immobilised on the
preformed patterned circular features.
Direct DPN
Although direct DPN patterning of biomolecules (process
B—Fig. 1) offer many potential advantages over indirect
immobilisation (e.g. complete absence of non-speciﬁc
binding and generation of multicomponent arrays with
increased complexity), it also poses several challenges.
Prominent among these challenges is the need for meth-
odologies that facilitate the transport of the high molecular
weight biomolecules from a coated tip to a substrate
without sacriﬁcing the sub-100 nm resolution and pat-
terning speed. Furthermore, DPN methodologies are
required that preserve the biological activity of the bio-
molecules during the direct biomolecular patterning.
Different strategies have been investigated and it has been
found that humidity [52, 84–86], modiﬁed AFM tips [52,
84–87] and afﬁnity template surfaces [46, 47, 52, 84–91]
are important parameters for controlling the biomolecule
nanopatterning process. For example, relative humidity
values as higher as 80–90% have been reported to be
necessary for a consistent tip-substrate transport of proteins
and subsequent optimum patterning results [52, 84].
AFM cantilevers have been chemically modiﬁed and
employed to immobilise DNA [86] and proteins [52, 84,
85, 87] on surfaces in a direct-write fashion. Improved
control over DNA patterning was achieved through surface
modiﬁcation of a silicon nitride AFM cantilever with 3-
aminopropyltrimethoxysilane, which promotes reliable
adhesion of the DNA ink to the tip surface [86]. Using
these modiﬁed AFM tips, patterns of DNA on both gold
(Fig. 3a) and oxidised silicon substrates (Fig. 3b) were
fabricated at sub-100 nm length scale. Thiol-modiﬁed
DNA molecules were patterned on gold and oligonucleo-
tides bearing 50-terminal acrylamide groups were patterned
on 3-mercaptopropyltrimethoxysilane-modiﬁed SiO2 sub-
strates. Using direct DPN, it was possible to pattern a two-
component DNA array on the oxidised silicon substrate and
demonstrate its sequence-speciﬁc activity by hybridisation
with complementary ﬂuorophore-labeled probes (Fig. 3c).
Chemically modiﬁed AFM tips have also been suc-
cessfully exploited to pattern proteins directly on bare gold
surfaces with features of 45 nm [52]. The modiﬁcation
procedure involved ﬁrst the functionalisation of the back-
side of a gold-coated cantilever with a protein-resistant
OEG-terminated alkanethiol SAM. Then, the silicon nitride
tip was selectively coated with gold and rendered hydro-
philic by a carboxylic acid-terminated SAM. The OEG-
terminated SAMs prevent the adsorption of protein on the
reﬂective gold surface of the cantilever, whereas the acid-
terminated SAMs facilitate the protein adsorption on the tip
surface. The direct-write DPN process allowed the nano-
patterning of two proteins (lysozyme and rabbit IgG) with
no cross-contamination (Fig. 4). In this approach, protein
adsorption was mainly driven by the binding of cysteine
thiol residues of the proteins to the gold surface.
The properties of the gold surfaces have also allowed
other thiol-containing biomolecules such as thiolated
376 Nanoscale Res Lett (2007) 2:373–384
123collagen [46] and thiol-containing peptides [46, 47, 88]t o
be directly immobilised on surfaces. Thiolated collagen
and collagen-like peptides molecules have been patterned
with line widths of 30–50 nm without the need for AFM tip
modiﬁcation [46]. Furthermore, the DPN deposition pro-
cedure preserved the triple-helical structure (Fig. 5) and
biological activity of collagen.
Other speciﬁc binding templates have been exploited to
pattern directly biomolecules on gold [84], glass [89], mica
[90], oxidised silicon [85] and nickel substrates [87, 91].
For instance, gold surfaces were coated with Prolinker
TM,
which contains crown ether moieties that can capture
protonated amines in protein structures by host–guest
interactions [84]. Using this strategy, nanoarrays of integrin
avb3 and angiogenin proteins have been fabricated with
feature widths of 120 and 60 nm, respectively. Glass sur-
faces were treated with 3-glycidoxypropyltrimethoxysilane
to generate patterns of human chorionic gonadotropin
antibody by direct-write DPN [89]. Protein nanoarrays with
sub-100 nm features have also been fabricated onto silicon
oxidised surfaces through electrostatic interactions between
the positively charged parts of the protein and the pre-
treated silica surface with base (rendering it negatively
charged), or through covalent bonding between aldehyde-
modiﬁed silicon oxidised surfaces and amine groups on the
protein molecules [85].
Electrochemical DPN [91] in the tapping mode of AFM
has been employed for direct immobilisation of poly-
histidine-tagged peptides and proteins on nickel substrates
via metal chelation. In this process, the AFM tip was ﬁrst
coated with the biomolecules, which were subsequently
delivered to the surface by applying an electrical potential
to the AFM tip. The water meniscus acted as a nanoscale
electrochemical cell, causing ionisation of the nickel sur-
face and localised binding of the poly-histidine-tagged
peptides and proteins. Using a different strategy, histidine-
tagged proteins (i.e. ubiquitin and thioredoxin) have also
been patterned on nickel surfaces with feature sizes as
small as 80 nm without the need for an applied potential
during the DPN process [87]. Reliable protein transport and
uniform protein patterning was achieved by coating the
AFM tips with a thin layer of nickel.
DPN is a versatile tool that has been used to immobilise
biomolecules such as DNA, peptides, proteins and virus on
various substrates with indirect- or direct-write methods.
Indirect methodologies have been effectively used to con-
trol the deposition of single biomolecules on substrates
[75]. By employing direct DPN patterning, feature sizes as
small as 30 nm were created [46], and it is reasonable to
expect that it will rival that of conventional DPN (15 nm)
[51]. Furthermore, biologically active biomolecule nano-
arrays have been fabricated over macroscopic distances
through parallel DPN [78]. Although two-component
Fig. 3 a Atomic force microscopy tapping mode image of thiol-
modiﬁed oligonucleotides DPN patterned on a gold surface [86]. b
Epiﬂuorescence image of ﬂuorophore-labeled DNA hybridised to a
DPN-generated pattern of complementary oligonucleotides on an
oxidised silicon surface [86]. c Combined red–green epiﬂuorescence
image of two different ﬂuorophore-labeled sequences simultaneously
hybridised to a two-sequence array deposited on an oxidised silicon
surface by DPN [86]
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DPN [52, 84], further equipment modiﬁcation and opera-
tion will be required for fabricating extensive multicom-
ponent arrays.
Nanoshaving
Nanoshaving is also a scanning probe microscopy-based
lithographic technique, in which a resist material is
mechanically removed by an AFM tip for creating nano-
metre scale patterns on surfaces (process C—Fig. 1). The
resolution and sharpness of the patterns depends not only
on local displacement, but also immediate removal of the
displaced adsorbate and suppression of readsorption [92].
The possibility for nanoshaving was ﬁrst explored in 1994
by Wendel et al. [93]. As well as fabricating holes, they
fabricated narrow trenches in poly(methyl methacrylate)
(PMMA) photoresist and gold layers. The AFM tip oper-
ating in tapping mode was used to shave away the soft gold
deposited on a hard substrate leading to feature widths of
approximately 50 nm. To date, these are the smallest fea-
tures achieved through nanoshaving.
Nanoshaving has been combined with SAMs as nano-
metre thickness resists for indirect immobilisation of
biomolecules on surfaces [94–98]. The nanoshaved pat-
terned surfaces have been exploited as templates for the
direct assembly of thiolated peptide nanotubes [96] and
proteins on gold substrates [97, 98]. SAMs of octadeca-
nethiol (ODT) were formed on gold surfaces, followed by
nanoshaving to selectively remove ODT from speciﬁc areas
on the surface [96–98]. Trenches up to 1 lm in length with
widths of 150 nm were fabricated [98]. Thiol–gold inter-
actions were then employed to immobilise the thiolated
peptide nanotubes [96] and IgG proteins via cysteine thiol
residues [97, 98] onto the patterned gold trenches. On the
basis of a two-step nanoshaving and protein immobilisation
process, two different antibodies (mouse IgG and human
IgG) were selectively immobilised on shaved nanotrenches
[98]. Anti-mouse IgG coated nanotubes and anti-human
IgG coated nanotubes were shown to speciﬁcally bind to the
complementary antibody-patterned surfaces.
In order to reduce the effects of non-speciﬁc protein
adsorption, protein-resistant ethylene glycol SAMs have
also been explored as resist materials for nanografting [99].
Protein immobilisation to the shaved regions was achieved
either through the chemisorption of a disulﬁde coupling
agent dithiobis(succinimidyl undecanoate) followed by IgG
protein binding or by the direct adsorption of Fab’-SH
fragment of goat anti-rabbit IgG antibody. The latter
approach holds considerable promising as a means of
fabricating multiple protein patterns. Even though nanos-
having does not offer extraordinary spatial resolution
(*150 nm [98]) for biomolecule immobilisation on sur-
faces, it has the capability of being used under ambient
Fig. 4 Two-component protein




binding of anti-rabbit IgG to
rabbit IgG patterned features
[52]
Fig. 5 Top and surface plot views of an AFM tapping mode image of
modiﬁed collagen molecules deposited on Au substrates by DPN [46]
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123conditions that could prove useful for fabrication of mul-
ticomponent biomolecule nanostructures.
Nanografting
An extension to the technique of nanoshaving is that of
nanografting [92, 100]. Compared to other methods of
nanofabrication, nanografting allows more precise control
over the size and geometry of patterned features and their
location on the surface. Features as small as 2 nm · 4n m
have been reported [101]. The technique of nanografting is
usually (but not exclusively) utilised on surfaces modiﬁed
with SAMs and is achieved by nanoshaving in the presence
of a second replacement surfactant molecule with a greater
afﬁnity for the surface than the molecule being removed by
the AFM tip. Therefore, once the pre-formed SAM is
removed from the desired area by the AFM tip it will be
replaced with a second surfactant to form a new SAM
in the patterned area. In order to successfully perform a
nanografting operation, there are certain requirements that
SAMs should meet. The SAMs must be readily removable
with the force applied by the AFM tip, but more impor-
tantly, the second surfactant must form the new SAM
rapidly. It is for these reasons that thiol SAMs on gold are
usually the system of choice for nanografting experiments,
due to the way in which thiols rapidly form homogenous
monolayers on exposed gold surfaces. This strategy has
been used for the production of nanometre-sized protein
patterns on gold surfaces by exploiting the afﬁnity of
biomolecules towards different SAMs.
Indirect Nanografting
Electrostatic interactions have been exploited in conjunc-
tion with nanografting for the fabrication of protein
nanopatterns [99, 102–104]. For instance, reactive carbox-
ylic acid-terminated SAMs were nanografted into methyl-
terminated SAMs on gold substrates [99, 103, 104]. Lyso-
zyme and IgG proteins were shown to adsorb selectively on
the patterned surfaces via electrostatic interactions between
the negatively charged acid-terminated regions and the
positively charged proteins [103, 104]. Line features as
small as 10 nm · 150 nm were fabricated (Fig. 6)[ 103].
More stable protein patterns have also been produced
by, for instance, formation of amide bonds between the
nanografted acid-terminated regions and the primary amine
groups in rabbit IgG using 1-ethyl-3-(3-dimethylamino-
propyl)carbodiimide hydrochloride (EDC) chemistry [99].
Imine bond formation has also been exploited to covalently
immobilise proteins on gold surfaces [103–105]. Nano-
grafting was employed to incorporate aldehyde-terminated
SAMs into methyl-terminated SAMs on gold substrates
[103–105]. Protein nanopatterned surfaces were subse-
quently produced through formation of imine bonds
between the aldehyde moieties on the patterned surfaces
and the primary amine groups in the IgG, lysozyme and
BSA proteins [103–105]. The proteins remained bioactive
on the surfaces and features as small as 40 nm · 40 nm
were generated [104, 105].
Direct Nanografting
Studies have also been conducted on the direct nanograft-
ing of DNA [106] and proteins on gold surfaces via thiol–
gold interaction [107, 108]. These approaches relied on a
well-controlled modiﬁcation of the DNA and proteins with
thiol groups. Designed metal-assembled three-helix bundle
metalloproteins [Fe(apVaLdC26)3]
2+, in which the three-
helices were speciﬁcally engineered with three cysteines
groups, were not only grafted on methyl-terminated SAMs,
but were also shown to adopt a vertical orientation on the
gold surface [107]. Using a similar methodology, lines of
DNA molecules as narrow as 10 nm were produced and
molecules were also shown to adopt a standing up orien-
tation on the gold surface [106].
Nanografting has been limited to the use of gold sub-
strates, but it offers the possibility of immobilising
biomolecules on these surfaces with resolution down to
10 nm [103]. As for DPN and nanografting, nanoshaving
allows the patterning of biomolecules on surfaces under
ambient conditions.
Electron-beam Lithography
Electron-beam lithography is a well developed and opti-
mised technique for semiconductor fabrication. The
Fig. 6 Lysozyme nanopatterns with a 10 nm · 150 nm line and a
100 nm · 150 nm rectangle formed through electrostatic interactions
between acid-terminated patterned surfaces generated by nanoshaving
and the negatively charged lysozyme protein. The lysozyme proteins
adopt different orientations when electrostatically immobilised on the
surface [103]
Nanoscale Res Lett (2007) 2:373–384 379
123resolution of EBL is not limited by the focus of the beam
(*1 nm), but by the size of the molecules in the resists and
secondary electron processes, such as electron scattering
and the proximity effect. EBL is capable of producing
features down to 5 nm in electron-sensitive resists such as
SAMs with high reliability and integral control over the
location of the features [109]. Although electron-beam
technology still has throughput issues, important advances
have been made in the development of parallel techniques/
tools such as projection e-beam lithography [110, 111] and
multibeam sources [112, 113].
Electron-beam lithography has been exploited to create
biological nanostructures by ﬁrst patterning a pre-formed
homogeneous ﬁlm, and subsequently attach the biomole-
cules of interest. Building on well-known sensitivity of
SAMs to electron irradiation [114], thiolates SAMs on gold
have been selectively removed by EBL and the exposed
areas used for creating bioactive templates [115, 116]. For
example, PEG monolayers on gold were patterned by
electron-beam to create biomolecular features with dimen-
sions of about 40 nm [116]. Depending on the electron
beam dose used, the SAM was removed from the gold
surface or some carbonaceous material was deposited on
the surface (i.e. contamination writing). Both patterned
surfaces were shown to immobilise neutravidin-coated
40 nm FluoSpheres with high selectivity [116]. A similar
electron-beam strategy was also applied to silane SAMs on
Si/SiO2 to create 250 nm patterns of DNA on these sub-
strates [117].
Metal-oxide nanopatterns have also been formed which
can subsequently direct the immobilisation of biomole-
cules [118, 119]. Indium-tin oxide (ITO)-glass substrates
were coated with a thin layer of SiO2, which was then
electron-beam patterned to expose nanoregions of the
underlying ITO. Dodecylphosphate, to which proteins can
bind, was selectively adsorbed on the ITO nanostructures,
whereas poly-L-lysine-g-poly(ethylene glycol) was used
to passivate the surrounding SiO2 regions against protein
adsorption [119]. Fluorescently labelled streptavidin
was shown to speciﬁcally adsorb to the hydrophobic ITO/
dodecylphosphate nanopatterned surfaces (*140 nm)
[119].
By combining EBL with a lift-off technique, metal
nanoarrays have been created for immobilising proteins on
Si/SiO2 surfaces [120, 121]. For instance, gold arrays
(1 lm to 45 nm in width) were generated for selective
immobilisation of disulﬁde-containing 2,4-dinitrophenyl-
caproate (DNP-cap) ligands [120]. The ligand patterned
surfaces were shown not only to bind with high speciﬁcity
to anti-DNP immunoglobulin E (IgE), but also to induce
speciﬁc cellular responses when incubated with rat baso-
philic leukaemia mast cells [120]. PMMA, which is widely
used as a lithographic positive resist, has been exploited in
conjunction with EBL for immobilising IgG [122] and
collagen proteins [123] on Si/SiO2 substrates. Collagen was
forced to align and assemble into continuous bundles by
the anisotropic dimensions of the electron-beam nanoscale
patterns (30–90 nm) [123].
Electron-beam lithography has also been carried out to
activate porous silicon [124] and polycaprolactone [125]
ﬁlms for further biomolecule immobilisation. Exposure of
the electron-beam irradiated polycaprolactone surfaces to
an acrylic acid solution in the presence of Mohr’s salt led to
a graft polymerisation of the acrylic acid on to the polymer
surface [125]. A three-step peptide immobilisation process
was then used to immobilise a cysteine-terminated RGD-
containing peptides onto the grafted surface. EBL has also
been exploited to locally crosslink amine-terminated
poly(ethylene glycol) ﬁlms to create hydrogel nanoarrays
with *200 nm features on silicon substrates [126].
BSA nanoarray pads were then generated by EDC chem-
istry. Two different BSA hydrogel nanoarray pads with
lateral dimensions of 5 lm · 5 lm on the same substrate
were further employed to immobilise two different
proteins, ﬁbronectin and laminin, via a photoactivate
heterobifunctional crosslinker [sulfosuccinimidyl-6-(40-
azido-20-nitrophenylamino)hexanoate] [126].
A particularly attractive feature of using EBL for nan-
opatterning biomolecules is its compatibility with standard
microfabrication techniques developed in the semicon-
ductor industry, allowing the diverse functions of
biomolecules to be easily integrated into, for example, bio-
nanoelectromechanical systems (bioNEMS) and sensor
devices. However, the principal drawbacks are that elec-
tron-beam modiﬁcation occurs under ultra-high vacuum
conditions, limiting the potential of this technique for
multicomponent biomolecule nanopatterning.
Nanocontact Printing
Microcontact printing (lCP) [127] is widely used for
generating micropatterns of nanomaterials such as organic
molecules [128, 129] and biomolecules [130–134] over
large surface areas (>cm
2). In the lCP process, a micro-
structured elastomer stamp is coated with a solution of a
nanomaterial and applied to a substrate of choice. Upon
contact with the substrate, the inked protrusions of the
pattern of the stamp deform slightly to make intimate
contact with the surface and facilitates diffusion from
the stamp to the substrate [127, 135]. After a given period
of time in conformal contact with the substrate, the stamp
is removed leaving a replica of the stamp pattern on the
substrate surface. The elastomer stamps are made typically
from poly(dimethylsiloxane) (PDMS) by curing liquid
prepolymers of PDMS on a lithographically prepared
380 Nanoscale Res Lett (2007) 2:373–384
123master. Since lCP technique is carried out under ambient
conditions, different biomolecules have been directly
transferred in a controlled way onto a variety of substrates
while retaining their biological activity [130–134]. By
combining lCP with a microﬂuid network, 16 different
proteins were successfully patterned into rows with mi-
crometre dimensions [131].
More recently, lCP concept has been extended to nano-
scale dimensions, a process referred to as nCP [135–137].
Features as small as 40 nm can now be fabricated by this
process [136]. Nanocontact printing has been achieved by
either decreasing the feature sizes in the PDMS stamp and
diluting the nanomaterial inks [137], utilising special
variants of PDMS stamps [135, 136] or employing new
polymeric material stamps (e.g. polyoleﬁn plastomers)
[138]. Another important factor on obtaining high-
resolution prints at the 100 nm level relates with the ink
utilised. In this context, biomolecules are attractive nano-
contact printing inks since their high molecular weight
prevents diffusion during the printing step, resulting in
high-resolution features.
By diluting the protein solution and decreasing the
feature size of the PDMS stamp, patterns of IgG and green
ﬂuorescent proteins with 100 nm wide lines were generated
on glass substrates [137]. A composite PDMS stamp, cast
from V-shaped gratings used for AFM tip characterisation,
was also used to print lines of titin multimer proteins on a
silicon surface with widths less than 70 nm (Fig. 7)[ 136].
The stamp design was based on a two layer stamp that uses
a thick ﬁlm of standard soft PDMS (Sylgard 184 PDMS) to
support a thin stiff layer of hard PDMS [135]. The hard
PDMS layer improved the mechanical stability of the
features on the stamp, reducing sidewall buckling and
unwanted sagging from the relief features [135, 136]. New
polyoleﬁn plastomer stamps were also exploited for cre-
ating ﬁbrinogen protein nanostructures on glass surfaces
[138]. The higher stiffness of these stamps allowed that
100 nm width lines of ﬁbrinogen could be fabricated with
superior quality than those resulting from PDMS stamps
[138].
A signiﬁcant advantage of nCP lithography compared to
serial techniques such as dip-pen lithography is that large
areas can be nanopatterned rapidly. Furthermore, as
opposed to the parallel conventional photolithographic
process, nCP is not diffraction limited and it should be
possible to pattern surfaces with molecular sized features.
The technique has been able, so far, to generate protein
patterns with dimensions of 70 nm [136]. Multicomponent
biomolecule nanopatterning is problematic with this tech-
nology due to the practical difﬁculties in accurately
aligning multiple ﬂexible stamps over a large area with
nanoscale resolution and thus further development is
required to solve this problem.
Summary and Outlook
A suite of bio-nanofabrication technologies now exist for
patterning a wide range of biomolecules such as DNA,
peptides, proteins and viruses on many types of materials.
These include DPN, nanoshaving, nanografting, EBL and
nanocontact printing (Table 1). Each of these techniques
has its own strengths and weaknesses with regard to reso-
lution, patterning speed, biocompatibility, complexity, and
cost. In particular, these reported strategies have the
common shortcoming of not being so far suitable for
nanopatterning of multiple biomolecule nanoarrays. For
instance, while dip-pen lithography exhibits high reliability
and precise control over the location of 30 nm biomolecule
features [46] and represents the state-of-the-art presently
Fig. 7 AFM tapping mode images of nanocontact printed titin
multimer protein lines on a silicon surface a at large scale and b at
high-resolution with height proﬁle cross section below [136]
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123for biomolecule patterning density [78], its multicompo-
nent biomolecule patterning capabilities have been
hindered by the signiﬁcant complexity involving both
equipment modiﬁcation and operation [52, 86]. Neverthe-
less, nanomanufacturing processes are evolving at fast
pace, with the future holding the promise of not only
providing innovative solutions to existing problems, but
also offering new opportunities through the development of
novel bio-nanoengineered surfaces.
Further paradigm shifts will be also driven by the need
for smart, bioactive and nanostructured materials, includ-
ing stimuli-responsive nanostructured materials. Develop-
ment of smart biological surfaces [139–141] that can
modulate the spatiotemporal biological properties at the
nanoscale represents a major, and exciting challenge, for
the future that may lead to new breakthroughs in the bio-
logical and medical sciences and ultimately, the delivery of
health care.
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